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Abstract
Introduction: Synovitis associated with osteonecrosis of the femoral head (ONFH) is responsible for several clinical symptoms. However, 
the mechanisms underlying synovitis and the inflammatory environment remain unclear. This study analysed the proinflammatory 
mediation expression of IL-17 and Th17, which perform key functions in regulating inflammatory processes in the inflamed synovium 
and peripheral blood in ONFH. 
Material and methods: Synovial fluid from the hips of 23 patients and five controls was collected during surgery, and peripheral blood 
samples were obtained from 34 patients and nine controls. The expression of IL-17 in the synovium was detected by immunohistochem-
istry, and the levels of Th17 and IL-17 in the blood were measured by flow cytometry and ELISA. Pain assessment was performed for all 
the patients and controls.
Results: An inflamed synovium was characterised by increased leukocyte infiltration and IL-17 expression in comparison with the control. 
Preoperative levels of Th17 and IL-17 were significantly higher in the peripheral blood of the ONFH group than those in the controls. 
The symptoms were also positively correlated with the Th17 levels of the ONFH patients.
Conclusion: Th17 cells were recruited to an inflamed synovium, and inflammatory cytokine IL-17 was expressed at an increased level 
in the hip synovium of ONFH patients, which possibly contributed to clinical syndrome development. Overall, this study will help to 
identify new therapeutic strategies for ONFH, especially the targeting of IL-17 to decrease inflammation and pain. (Endokrynol Pol 2018; 
69 (3): 283–290)
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Streszczenie
Wstęp: Zapalenie błony maziowej związane z martwicą głowy kości udowej (osteonecrosis of the femoral head; ONFH) odpowiada za kilka 
objawów klinicznych, jednak mechanizmy leżące u podstaw zapalenia błony maziowej oraz środowisko zapalne pozostają niejasne. 
W niniejszym badaniu poddano analizie ekspresję mediatora zapalenia IL-17 na limfocytach Th17, które pełnią kluczową rolę w regulo-
waniu procesów zapalnych w objętej stanem zapalnym błonie maziowej i krwi obwodowej w przebiegu ONFH. 
Materiał i metody: Podczas zabiegów operacyjnych pobrano maź stawową ze stawów biodrowych 23 pacjentów i 5 osób z grupy kon-
trolnej, natomiast próbki krwi obwodowej uzyskano od 34 pacjentów i 9 osób z grupy kontrolnej. Ekspresję IL-17 w błonie maziowej 
wykrywano za pomocą metody immunohistochemicznej, a stężenie Th17 i IL-17 we krwi mierzono metodą cytometrii przepływowej 
i metodą ELISA. U wszystkich pacjentów i osób z grupy kontrolnej oceniono parametr bólu.
Wyniki: Cechą charakterystyczną objętej stanem zapalnym błony maziowej był wzrost nacieczenia limfocytarnego i ekspresji IL-17 
w porównaniu z grupą kontrolną. Stężenie Th17 i IL-17 przed wykonaniem zabiegów operacyjnych było znacząco wyższe we krwi ob-
wodowej pacjentów z martwicą głowy kości udowej niż grupy kontrolnej. Również objawy były u tych pacjentów dodatnio skorelowane 
z poziomem Th17. 
Wnioski: Limfocyty Th17 były rekrutowane do objętej stanem zapalnym błony maziowej, a cytokina zapalna IL-17 ulegała ekspresji na 
zwiększonym poziomie w błonie maziowej stawu biodrowego pacjentów z martwicą głowy kości udowej, co prawdopodobnie przyczyniło 
się do rozwoju zespołu objawów klinicznych. Ogólniając, niniejsze badanie może pomóc zidentyfikować nowe strategie terapeutyczne 
w martwicy głowy kości udowej, w szczególności ukierunkowane na IL-17 w celu zmniejszenia stanu zapalnego i bólu. (Endokrynol 
Pol 2018; 69 (3): 283–290)
Słowa kluczowe: limfocyty pomocnicze Th17, IL-17, martwica głowy kości udowej, zapalenie, ból, wizualna skala analogowa
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Introduction
Osteonecrosis of the femoral head (ONFH) is a devastat-
ing disease for affected patients, with complete collapse 
of the femoral head occurring in 80% of untreated pa-
tients [1, 2]. Trauma, alcoholism, excessive steroid use, 
sickle cell anaemia, damage from radiation, Gaucher’s 
disease, and exposure to high pressure are reported to 
be the potential reasons for ONFH [3]. Chronic pain is 
one of the features of this disease, which is considered 
to be associated with synovitis caused by a series of 
inflammatory molecules [4]. To date, the pathophysiol-
ogy of ONHF remains poorly understood, but secreted 
inflammatory molecules (such as proinflammatory cy-
tokines) are believed to be among the critical mediators 
of the pathophysiological processes [5, 6]. However, the 
release of proinflammatory cytokines in an inflamed 
synovium has rarely been investigated.
Chronic pain is the most remarkable symptom that 
seriously disturbs ONFH patients. Osteonecrosis can be 
categorised into four stages according to a previously 
published grading system [7]. The level of pain varies 
among patients. Severe sufferers may complain of 
a considerable impact on their normal lives, whereas 
others may only declare discomfort in the hip joint. 
These findings may be related to synovitis during 
ONFH pathogenesis; previous studies found that in-
flammatory synovium is infiltrated with CD4+ T cells, 
macrophages, and some CD8+ T cells [8]. Inflammatory 
factors, such as tumour necrosis factor alpha (TNF-a) 
[9], nitric oxide (NO) [10], interleukin (IL)-33 [11], and 
several adhesion molecules [8], also participated in the 
pathogenesis of synovitis. Interestingly, these inflamma-
tory cells and cytokines were reported to be involved 
in pain severity [12–14].
IL-17 has been reported to be expressed at increased 
levels in inflamed osteoarthritis synovium [15, 16], 
and closely related to pain. In healthy individuals, 
approximately 1% of CD4+ T cells in their peripheral 
blood are Th17 cells [17]. During pathological processes, 
Th17 cells can be recruited to lesions and produce IL-17 
and TNF-a to mediate inflammatory reactions [18–21]. 
Moreover, IL-17 is proven to be able to stimulate fi-
broblasts, chondrocytes, and synovial cells to produce 
other proinflammatory cytokines, including IL-6, as 
well as prostaglandin E2 (PGE2) and NO [22–24]. All 
these cytokines are thought to act on local lesions and 
induce clinical symptoms, such as inflammation and 
pain. In the present study, we focused on the alteration 
of Th17 and the expression of IL-17 in ONFH, and we 
explored the potential relationship between Th17 level 
and pain severity.
Material and methods
Ethics statement
Patients were enrolled between October 2012 and May 
2014 at Qianfoshan Hospital, Shandong University, 
China. Our research was approved by the Medical 
Ethical Committee of Shandong University. Written, 
informed consent was obtained from each participant.
Stages of ONFH
We divided the ONFH into four clinical stages mainly 
by iconography and clinical manifestation according to 
a previously published grading system [7].
Immunohistochemistry
For immunohistochemistry (IHC) analysis, which im-
plied regional expression of targeted molecules, femo-
ral head tissues were collected during surgery from 
23 patients (all patients were in Stage 4) with ONFH 
and five controls with transcervical fracture. Freshly 
isolated synovium from each patient was immediately 
fixed in 4% paraformaldehyde in phosphate-buffered 
saline (PBS). Transverse and coronal sections of 5 µm 
thickness were deparaffinised in xylene, rehydrated 
though graded ethanol, and stained with Alcian blue, 
as well as eosin and propidium iodide. Prior to staining, 
the sections were treated with 3% H2O2 for 10 min to 
inactivate catalase and with bovine serum albumin to 
block nonspecific antigens. To identify the inflammatory 
environment, the sections were incubated with rabbit 
anti-human TNFa antibody (Abcam Inc., USA) in PBS 
at a dilution of 1:100. To localise Th17, the sections were 
incubated with rabbit anti-human IL-17 antibody (5 µg/ 
/mL, R&D Systems Inc., USA) in PBS at dilutions of 1:300, 
1:500, and 1:300. All the sections were incubated at 4°C 
overnight. After the sections were thoroughly washed, 
the bound primary antibody was incubated with 
secondary antibody (working solution of LiankeBio) 
for 20 min in Reagent A and 20 min in Reagent B. Colour 
was developed using diaminobenzidine (Abcam Inc., 
USA). The negative control for the primary antibody 
used PBS instead of the antibody.
Grading of immunostained sections
Semi-quantitative grading of IL-17 immunoreactivity 
in immunostained sections was separately performed 
by two investigators, who evaluated nine separate 20× 
magnification fields for each tissue sample. The method 
used here was described by Shamji et al. [25], and the 
strategy provided the most complete and comprehen-
sive evaluation of surgical tissue samples. The degree 
of cytokine immunoreactivity was scored as follows: 
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0 = no positive cells and 1 = at least one positively 
labelled cell.
Enzyme-linked immunosorbent assay (ELISA)
The circulating levels of Th17 and IL-17 were evaluated 
in the blood samples. Peripheral blood was obtained from 
34 patients (six for stage 1, 13 for stage 2, six for stage 
3, and nine for stage 4) with ONFH and nine controls 
with transcervical femoral fracture. The samples were 
analysed using a Human Th17 ELISA kit (eBioscience, 
BMS2017HS) following the manufacturer’s instructions. 
All procedures were performed at room temperature, 
and the mean absorbance of the standards and samples 
was detected in duplicate. Colorimetric reactions were 
analysed at 450 nm on a Varioskan flash multifunction 
plate reader (Thermo Scientific, Germany). All the experi-
ments were repeated at least three times.
Flow cytometry
We analysed the percentage of Th17 in the peripheral 
blood of the patients via flow cytometry. Flow cyto-
metry was used to evaluate the intracellular IL-17 pro-
duction and identify the Th17 cytokine-producing cells 
in both the ONFH and transcervical fracture groups. 
Briefly, heparinised peripheral whole blood (300 µL) 
added with an equal volume of Roswell Park Memorial 
Institute (RPMI) 1640 medium was incubated for 5 h at 
37°C, with 5% CO2 in the presence of 25 ng/mL phorbol 
myristate acetate (PMA) (ENZO, BML-PE160-0001), 
1 µg/mL ionomycin (ENZO, ALX-450-007-M001), and 
1.7 µg/mL monensin (ENZO, 380-026-M100). After 
incubation, the cells were stained with phytoerythrin 
(PE)–Cy5-conjugated anti-human CD3 (eBioscience, 
15-0038-42) and fluorescein isothiocyanate-conjugated 
anti-human CD8 monoclonal antibodies (eBioscience, 
11-0088-42) at room temperature in the dark for 15 min 
to delimitate CD4+ T cells. The cells were then fixed, 
permeabilised (LiankeBio, LK-GAS003, FIX&PERM Kit), 
and stained with a PE-conjugated anti-human IL-17A 
monoclonal antibody (eBioscience, 12-7178-41). Isotype 
controls were used to enable correct compensation and 
confirm the antibody specificity. Stained cells were 
analysed by flow cytometry on a fluorescence-activated 
cell sorter (FACS) cytometer equipped with CellQuest 
software (BD Bioscience Pharmingen, San Jose, CA). Fi-
nally, the CD3+ and CD4+ T cell subsets were gated by 
flow cytometry, and the proportion of IL-17-producing 
cells was determined.
Pain rating scale
We used the visual analogue scale (VAS) [26] to evaluate 
the pain level of the patients. All the patients were given 
a VAS noted list for self-evaluation of their pain at rest. 
The scale of pain was matched with the IHC results.
Statistical analysis
Data were expressed as the mean ± standard deviation 
(SD). Flow cytometry and ELISA data were statistically 
analysed by one-way analysis of variance (ANOVA) 
with post-hoc analysis. Differences between study 
groups in tissue immunoreactivity scores were exam-
ined using Chi-squared test. A bivariate correlation 
was used to determine the relationship between the 
VAS scores and the Th17 and IL-17 levels. All the tests 
were performed using SPSS 16.0. A value of P < 0.05 
was considered statistically significant.
Results
Th17 was expressed in inflamed synovium
To investigate the expression pattern of Th17 and IL-17, 
IHC was conducted in synovium samples collected 
from patients with ONFH and transcervical fracture. 
Blood vessel hyperplasia, infiltration of inflammatory 
cells, and upregulation of TNFa were observed in the 
synovium samples of the ONFH group (Figure 1A, 1B, 
and 1C). Conversely, substantially milder inflammation 
was observed in transcervical fracture samples. Further-
more, we confirmed the infiltration of Th17 in ONFH by 
immunostaining for IL-17. The expression of IL-17 was 
markedly increased in the ONFH samples (Figure 1D) 
in comparison with the fracture samples (Figure 1E). 
Statistical analysis of IL-17 based on IHC indicated 
that the expression of IL-17 between the two groups 
presented a significant difference (Figure 1F). Overall, 
our results reveal that the inflammatory reaction in the 
synovium of the ONFH patients and the IL-17 level may 
participate in this process.
Levels of Th17 and IL-17 in peripheral blood were 
elevated in patients with ONFH
Representative flow cytometry was conducted to detect 
the Th17 level in peripheral blood (Figure 2). The results 
showed that the percentage of Th17 cells significantly 
increased in the ONFH group compared with that in the 
transcervical fracture group. The IL-17 expression level 
in the peripheral blood was also tested by ELISA, and 
the expression of IL-17 in the ONFH group was mark-
edly promoted (Figure 3). These results imply that apart 
from regional infiltration in the synovium, upregulation 
of Th17 also occurs in the peripheral blood, and the 
latter may be a prerequisite for the former.
Th17 level is positively correlated with VAS pain 
scores and clinical stages of ONFH
We evaluated the association between Th17 and pain 
sensation via a semi-quantitative pattern. We found that 
higher grading of synovial Th17 distribution is observed 
with higher VAS score of pain (Figure 4A). Pearson’s 
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Figure 1. Patients with ONFH displayed inflammation environment and immunohistochemical localisation of IL-17 in synovium 
surrounding the femoral head. A and B: severe blood vessel hyperplasia and infiltration of inflammatory cells in samples with ONFH, 
as detected through immunohistochemistry. Twenty-three synovial tissue samples from patients with ONFH and five from patients with 
transcervical fracture as controls were analysed. Representative results from each group are shown; C. Expression pattern of TNF-a 
pathological tissue of ONFH, as assayed by immunohistochemistry; D. Representative IL-17 expression in samples from the ONFH 
group; E. No distinct IL-17 expression was detected in the control group; F. Semi-quantitative grading methods were used to analyse 
the immunohistochemical results. Compared with the control group, the expression of IL-17, as shown by the mean grading scores of 
the positive cells, significantly increased in the ONFH group (F, P < 0.0001, significantly different from the controls)
Rycina 1. Pacjenci z martwicą głowy kości udowej wykazywali stan zapalny oraz lokalizację immunohistochemiczną IL-17 w błonie 
maziowej otaczającej głowę kości udowej. A, B. Poważny przerost naczyń krwionośnych oraz nacieczenie komórek zapalnych w próbkach 
z martwicą głowy kości udowej wykryte za pomocą metody immunohistochemicznej. Analizie poddano 23 próbki tkanki maziowej od 
pacjentów z martwicą głowy kości udowej oraz 5 próbek od pacjentów ze złamaniem szyjki kości udowej. Przedstawiono reprezentatywne 
wyniki z każdej grupy; C. Wzorzec ekspresji TNF-a w patologicznej tkance objętej martwicą głowy kości udowej, wykryty za pomocą 
metody immunohistochemicznej; D. Reprezentatywna ekspresja IL-17 w próbkach z grupy pacjentów z martwicą głowy kości udowej; 
E. W grupie kontrolnej nie wykryto wyraźnej ekspresji IL-17; F. Do analizy wyników immunohistochemicznych wykorzystano półilościowe 
metody klasyfikacji. Jak pokazują średnie wyniki ocen komórek dodatnich, ekspresja IL-17 znacząco wzrosła w grupie pacjentów 
z martwicą głowy kości udowej w porównaniu z grupą kontrolną (F, P < 0,0001, znacząco różne od grupy kontrolnej)
F
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R-test was performed, and the positive correlation (R2 
= 0.9207) between grading points of synovial Th17 and 
VAS scores was evaluated. We also found a positive 
correlation (R2 = 0.6473 and 0.7333, correspondingly) 
between the levels of Th17 and IL-17 in the peripheral 
blood and VAS points (Figure 4B and 4C). At different 
stages of ONFH, the peripheral IL-17 level also varied. 
In stage 1 to stage 3, the levels of IL-17 showed relatively 
low levels, whereas in stage 4, IL-17 increased to a much 
higher level (Figure 4D and 4E).
Discussion
Although synovitis is an integral component of ONFH, 
the mechanism responsible for its development and its 
precise contribution to ONFH initiation and progression 
is far from clearly understood. On the one hand, ONFH 
synovium inflammation has been suggested to be associ-
ated with macrophage and CD4(+) T-cell infiltration [4, 8]. 
On the other hand, synovitis may favour ONFH pro-
gression via proinflammatory cytokines.
In the present study, we investigated the involve-
ment of Th17 lymphocytes in ONFH through a com-
parison of pathological specimens and peripheral 
blood samples from patients with ONFH and controls 
with transcervical fracture. ONFH synovium samples 
showed diffuse inflammation. The ratio of blood vessel 
hyperplasia and infiltration of inflammatory cells was 
significantly larger in the ONFH synovium than in the 
transcervical fracture samples. Additionally, a consider-
able amount of leukocyte clusters existed in the ONFH 
synovium compared with those in the transcervical 
fracture samples. The higher levels of Th17 and IL-17 
in the ONFH synovium indicated the correspondence 
between biochemistry and inflammation in synovitis. 
Previous studies have proven that IL-17 can induce the 
expression of PGE2, IL-6, and NO [22–24], which are 
critical mediators of inflammation and pain. We aimed 
Figure 2. Th17 frequency in ONFH patients and control group. Peripheral blood samples were collected from experimental and control 
groups, and Th17 cells were isolated. A. Lymphocytes were gated by flow cytometry; B. CD3+ T subsets were gated by flow cytometry. 
Plots in the internal box represent CD3+ T cells; C and D. The proportions of Th17 to CD3+CD8−(CD4+) subsets from representative 
controls and ONFH group are shown, respectively. The percentage of circulating Th17 cells was significantly higher in ONFH patients 
than in the control group (E, P < 0.0001, significantly different from the control)
Rycina 2. Częstość występowania limfocytów Th17 u pacjentów z martwicą głowy kości udowej i w grupie kontrolnej. Próbki krwi 
obwodowej zostały pobrane od osób z grupy eksperymentalnej i grupy kontrolnej, jak również limfocyty Th17 zostały wyizolowane. 
A. Limfocyty były bramkowane metodą cytometrii przepływowej; B. Subpopulacja limfocytów T CD3+ była bramkowana metodą cytometrii 
przepływowej. Wykresy w wewnętrznym polu przedstawiają limfocyty T CD3+; C, D. Proporcje limfocytów Th17 do subpopulacji 
CD3+CD8−(CD4+) z reprezentatywnej grupy kontrolnej i grupy z ONFH, odpowiednio. Odsetek krążących komórek Th17 był znacząco 
wyższy u pacjentów z martwicą głowy kości udowej niż w grupie kontrolnej (E, P < 0,0001, znacząco różne od grupy kontrolnej)
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to determine whether Th17 also performs a function 
in the ONFH, i.e. in manifestation of pain. The present 
results showed that IL-17 is expressed in the inflamed 
synovium of ONFH. As a control, the expression of IL-17 
in the patients with transcervical fracture remained at 
a relatively low level. Another significant observation 
is the elevated levels of CD3+, CD4+, and IL-17+ cells 
in the peripheral blood of ONFH patients; consistently, 
the level of IL-17 in the peripheral blood also increased 
in association with pain severity. The results showed 
that patients with higher VAS scores presented en-
hanced levels of Th17 and IL-17, both in the regional 
synovium and peripheral blood. Overall, these findings 
indicated that Th17 cells may participate and perform 
a key function in the inflammatory process and clinical 
symptoms of ONFH.
Inflammation in the ONFH group was apparently 
more severe than that in the controls, with higher levels 
of accumulation of inflammatory cells, hyperplasia of 
the blood vessels, and high expression of TNFa [27]. 
Figure 4. Scatter plots of the correlation of VAS pain score and IL-17 level in regional tissue and peripheral blood. The semi-quantitative 
grading scores of IL-17 in the pathological tissue of ONFH patients increased along with VAS scores (A, R2 = 0.9207, significantly positive 
correlation between the two factors). The percentage of Th17 and the concentration of IL-17 in the peripheral blood of ONFH patients 
also trended in a positive pattern with the VAS scores (B, R2 = 0.6473; C, R2 = 0.7333, evident positive correlation between two factors). 
IL-17 levels differed markedly in four different clinical stages (D, P < 0.05, significant difference between stage 4 and other stages), 
but the linear correlation between IL-17 and clinical stage was weak (E, R2 = 2723, weak positive correlation between the two factors)
Rycina 4. Wykresy punktowe przedstawiające zależność między wizualną skalą analogową nasilenia bólu a stężeniem IL-17 w tkance 
miejscowej i krwi obwodowej. Półilościowe wyniki klasyfikacji IL-17 w tkance patologicznej pacjentów z martwicą głowy kości udowej 
wzrastały razem z wynikami wizualnej skali analogowej (A, R2 = 0,9207, istotna dodatnia korelacja między obydwoma czynnikami). 
Odsetek limfocytów Th17 i stężenie IL-17 we krwi obwodowej pacjentów z martwicą głowy kości udowej również wykazywały tendencje 
dodatnie z wynikami wizualnej skali analogowej (B, R2 = 0,6473; C, R2 = 0,7333, ewidentna dodatnia korelacja między obydwoma 
czynnikami). Stężenia IL-17 różniły się znacznie w czterech różnych stadiach klinicznych (D, p < 0,05, istotna różnica między stadium 
czwartym a pozostałymi stadiami), lecz korelacja liniowa między IL-17 a stadium klinicznym była słaba (E, R2 = 2723, słaba dodatnia 
korelacja między obydwoma czynnikami)
Figure 3. Comparison of IL-17 level in peripheral blood between 
the two groups. The level of IL-17 was apparently greater in 
the ONFH group than that in the control group (P < 0.0017, 
significantly different from the controls)
Rycina 3. Porównanie stężenia IL-17 we krwi obwodowej obu 
grup. Stężenie IL-17 było niewątpliwie wyższe u pacjentów 
z martwicą głowy kości udowej niż w grupie kontrolnej 
(P < 0,0017, znacząco różne od grupy kontrolnej)
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These findings support the view that ONFH represents 
a typical “inflammatory disease” and implies a potential 
network among inflammatory cells and cytokines. Th17, 
a typical inflammatory cell type with its mediated IL-17, 
is defined as a key player in various autoimmune dis-
eases [16, 23, 24]. In the current study, the local level of 
IL-17 in the synovium of the ONFH group was found 
to be markedly higher than that in the controls, sug-
gesting a local accumulation of Th17. This result implies 
a positive relationship between Th17 and inflammatory 
ONFN. Circulating Th17 and IL-17 are well-established 
biomarkers for the severity of inflammatory diseases. 
Interestingly, higher levels of circulating Th17 and 
IL-17 were detected in the ONFH group, indicat-
ing a “circulating source” of the regional Th17 [28]. 
As a chronic pathological process, ONFH may induce 
the inflammatory reaction of the organism and produce 
more Th17 and IL-17, which in turn exacerbates inflam-
mation. Collectively, the expression of Th17 may exist as 
a consequence of ONFH-induced inflammation while 
participating in pain severity among patients.
One of the dominant factors of ONFH is pain se-
verity [29]. Moreover, severe pain is a key driver for 
ONFH treatment, and pain relief is a preliminary goal 
of therapy [30].
We performed a correlation analysis between IL-17 
and VAS scores in our study, and the results revealed 
a typical positive association between the two param-
eters. This finding suggests that Th17 may be involved 
in the pain induction of ONFH. Subsequently, we per-
formed a similar analysis between Th17 and IL-17 in 
the peripheral blood and VAS scores, and we obtained 
similar results. In summary, Th17 and its induced IL-17 
are closely related to ONFH pain. We assume that the 
peripheral Th17 cell was recruited to the local synovium 
to induce inflammation, and the secreted IL-17 may 
stimulate synovial cells to produce PGE2 and NO, 
thereby causing pain.
In conclusion, our research indicates that Th17 
and IL-17 may participate in synovium inflammation 
of ONFH, as well as in the pathogenesis of ONFH. 
Th17 and IL-17 possibly contribute to pain sensation 
in ONFH. Overall, our study may provide a potential 
therapeutic target for ONFH and pain relief.
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